⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10079823 | 0.88 | — | — | |
| Ammonia Solution, Strong SCHEMBL4272086 | 0.82 | — | — | |
| Chloromethane SCHEMBL8192571 | 0.80 | — | — | |
| Trichloroethane SCHEMBL64609 | 0.72 | — | — | |
| SCHEMBL5928 | 0.72 | — | — | |
| SCHEMBL7490 | 0.72 | — | — | |
| SCHEMBL538106 | 0.72 | — | — | |
| Trichloroethane SCHEMBL3833855 | 0.72 | TSHR (1.00) | — | |
| SCHEMBL10649555 | 0.72 | — | — | |
| Trichloroethane SCHEMBL16434 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4419094-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPROLIFERATIVE, INFLAMMATORY, AND IMMUNOLOGICAL DISEASES, AND INFECTIONS | Edison Oncology (US) | 2024-08-28 | — | — | EP | claimed |
| WO-2023069727-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPROLIFERATIVE, INFLAMMATORY, AND IMMUNOLOGICAL DISEASES, AND INFECTIONS | EDISON ONCOLOGY (US) | 2023-04-27 | — | — | WO | claimed |
| US-20190091195-A1 | USE OF DIANHYDROGALACTITOL AND DERIVATIVES THEREOF IN THE TREATMENT OF GLIOBLASTOMA, LUNG CANCER, AND OVARIAN CANCER | DEL MAR PHARMACEUTICALS (CA) | 2019-03-28 | — | — | US | claimed |
| WO-2017042634-A2 | USE OF DIANHYDROGALACTITOL OR DERIVATIVES AND ANALOGS THEREOF FOR TREATMENT OF NON-SMALL-CELL LUNG CARCINOMA, GLIOBLASTOMA, AND OVARIAN CARCINOMA BY INDUCTION OF DNA DAMAGE AND STALLING OF CELL CYCLE | DEL MAR PHARMACEUTICALS (CA) | 2017-03-16 | — | — | WO | claimed |
| US-7196054-B1 | Methods for treating wound tissue and forming a supplemented fibrin matrix | THE AMERICAN NATIONAL RED CROSS (US) | 2007-03-27 | — | — | US | claimed |
| US-RE39321-E1 | Supplemented and unsupplemented tissue sealants, methods of their production and use | THE AMERICAN NATIONAL RED CROSS (US) | 2006-10-03 | — | — | US | claimed |
| US-20030232014-A1 | Mass spectrometry-based procedure for detection of amino acid modifications, such as phosphorylation; drug discovery | MDS PROTEOMICS INC. (CA) | 2003-12-18 | — | — | US | claimed |
| WO-2003037172-A9 | ENDOTHELIAL-CELL BINDING PEPTIDES FOR DIAGNOSIS AND THERAPY | GPC BIOTECH INC (US) | 2003-12-11 | — | — | WO | claimed |
| WO-2003074992-A2 | PHOSPHORYLATED PROTEINS AND USES RELATED THERETO | MDS PROTEOMICS INC. (CA) | 2003-09-12 | — | — | WO | claimed |
| US-20030166004-A1 | Endothelial-cell binding peptides for diagnosis and therapy | GPC BIOTECH INC. | 2003-09-04 | — | — | US | claimed |
| WO-2003037172-A2 | ENDOTHELIAL-CELL BINDING PEPTIDES FOR DIAGNOSIS AND THERAPY | GPC BIOTECH INC. (US) | 2003-05-08 | — | — | WO | claimed |
| WO-2001072958-A2 | BLADDER CANCER-SPECIFIC PEPTIDES FOR DIAGNOSIS AND THERAPY | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 2001-10-04 | — | — | WO | claimed |
| US-6054122-A | A FOAMABLE FIBRIN MATRIX COMPRISING FIBRINOGEN OR METABOLITE AND AN FOAMING AGENT WHICH CAUSES FIBRINOGEN TO FOAM DURING APPLICATION OF FIBRINOGEN TO WOUNDED TISSUE | THE AMERICAN NATIONAL RED CROSS (US) | 2000-04-25 | — | — | US | claimed |
| US-20260137781-A1 | Antibodies and Immunotherapies That Target the Active Conformation of Integrin Beta 2 | THE REGENTS OF THE UNIV OF CALIFORNIA (US) | 2026-05-21 | — | — | US | disclosed |
| US-12628858-B2 | Therapy for colorectal and small intestine cancers | CORNELL UNIVERSITY (US) | 2026-05-19 | — | — | US | disclosed |
| US-12606628-B2 | Antibodies targeting integrin beta-2 | SINGH SIDHU SACHDEV (CA) | 2026-04-21 | — | — | US | disclosed |
| EP-0614527-A4 | GEL PARTICLE CONTRAST MEDIA FOR IMPROVED DIAGNOSTIC IMAGING. | UNGER EVAN C (US) | 1998-06-03 | — | — | EP | disclosed |
| EP-0614527-A1 | GEL PARTICLE CONTRAST MEDIA FOR IMPROVED DIAGNOSTIC IMAGING | ImaRx Pharmaceutical Corp. (US) | 1994-09-14 | — | — | EP | disclosed |
| US-5336329-A | Treating contaminated surfaces with particles of partially decomposed macroporous polymeric adsorbents which have pores filled with hydroxides of sodium, potassium or lithium | ROHM AND HAAS COMPANY (US) | 1994-08-09 | — | — | US | disclosed |
| WO-1993010440-A1 | GEL PARTICLE CONTRAST MEDIA FOR IMPROVED DIAGNOSTIC IMAGING | UNGER EVAN C (US) | 1993-05-27 | — | — | WO | disclosed |